1,355,069 research outputs found
Accomplishments, engagements and new challenges for the Monaldi Archives for Chest Disease
No full textThe Editors: Antonio Spanevello, Bruno Balbi Another year has passed, and we would like to thank and recognize all of the many members who have contributed to the editorial process and content of Monaldi during 2018. Our submissions are increasing, citations for our papers are rising, and recognition of the journal is broadening. Not settled for focusing on past goings-on only, we now direct our efforts toward building an even greater impact
A new Editorial Board of Monaldi Archives for Chest Disease
No full textIn recent years, Monaldi has reached a widespread diffusion and consolidated its reputation as a good quality scientific journal in the field of cardiopulmonary rehabilitation. Many of these achievements are due to the hard work of many pulmonary physicians, most of them, including the last two former Editors, Claudio F. Donner and Ciro Rampulla, part of the FSM and distinguished leaders of research groups in their field. Commercing in 2002, Monaldi has divided the published issues in a Cardiologic and in a Pulmonary Series, issued separately.
This year, FSM decided to renew also the Editorial Board of the Pulmonary series. Beginning with the present issue we (Antonio Spanevello and Bruno Balbi) are the two new Co-Editors. We are currently Head and Scientific Secretary, respectively, of the Pulmonary Rehabilitation Department, the organization that comprises the Pulmonary Physicians working at FSM. As Editors we will work together with two Deputy Editors (Dr. Mirco Lusuardi, Head of Pulmonary Rehabilitation, Health Authority of Reggio Emilia and Dr. Maurizio Luisetti, Head of Biochemistry and Genetics in Pulmonary Medicine, University of Pavia) and two Executive Editors (Dr. Giuseppe Brunetti and Dr. Luca Bianchi, both at FSM). This “under fifty” Editorial Board, is deeply committed to doing the best for our Journal and to continue and extend the precious work done by the previous Editors.
We heritage a healthy and well-nourished scientific journal. It is an honor and a privilege to take over as Editors from Ciro Rampulla and we thank him for his wise and culturally rich contribution to Monaldi. As Editor in Chief of the past Editorial Board in the last 2 years Ciro worked hard and refined the editorial and administrative procedures, with the full support of the FSM. His example will be a guide for us to chair the Editorial Board of the Journal
The psychological needs of patients affected by chronic obstructive pulmonary disease or asthma in rehabilitative settings: The «PsiRiResp» explorative study
No full textChronic obstructive pulmonary disease (COPD) and asthma are major causes of morbidity and mortality, and their management requires a rehabilitative multidisciplinary approach. The presence of anxiety and/or depression in COPD and asthma patients is associated with poor adherence, increased mortality, exacerbation rates and length of hospital stay and decreased quality of life and functional status. In a rehabilitation team, the psychologist could improve the screening of patients’ psychological needs and their treatments. Based on available evidence, this study proposes a multidisciplinary team-working model to support early screening and the integration of psychological contributions to the care of inpatients with COPD or asthma. For patients who are also experiencing clinical or sub-threshold psychological upset, low to high intensity psychosocial interventions could include brief and targeted cognitive behavioural therapy (CBT), relaxation and self-management of emotional states, and multidisciplinary educational sessions. The aims of this project are to activate early assessment to search for the burden of psychological needs in COPD or asthmatic patients and to improve quality of care
Complications of SARS-CoV-2 Infection During Cardiac Rehabilitation: A Case Series
No full textIntroduction: Vaccination strongly reduces the risk of hospitalization and death due to coronavirus disease 2019 (COVID-19). However, the severity of the acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection and the degree of protection exerted over time by vaccination remains to be fully elucidated among hospitalized comorbid and vulnerable patients with SARS-CoV-2 infection. Methods: We report a case series of nine hospitalized vulnerable patients who developed a SARS-CoV-2 infection during a cardiac rehabilitation inpatient program. Results: Age ranged from 50 to 81 years. All but one patient had received at least three doses of anti-COVID-19 vaccine more than 4 months before the cardiac event. Indications for cardiac rehabilitation included acute coronary syndromes, congestive heart failure, heart valve surgery, and coronary artery bypass graft. After the confirmed diagnosis of SARS-CoV-2 infection, all patients developed symptoms. Eight patients developed at least one SARS-CoV-2-related complication, including a significant increase in high-sensitivity troponin I levels, new-onset hypoxemia, persistent atrial fibrillation, non-sustained ventricular tachycardia and recurrent sinus arrest, pericardial effusion, and a persistent increase in blood pressure. Conclusion: Almost all patients developed complications which, however, did not evolve towards more severe expressions of the disease. These data suggest that even in this new phase of the pandemic, vaccination may exert a potential role to reduce the risk of progression towards more severe disease of SARS-CoV-2 infection in vulnerable patients with cardiovascular comorbidities
Pulmonary rehabilitation: Promising nonpharmacological approach for treating asthma?
No full textPurpose of reviewAsthma is a heterogeneous disease, usually characterized by chronic airway inflammation with a history of respiratory symptoms that vary over time and in intensity, together with variable expiratory airflow limitation. The goal of asthma treatment is to reach symptoms control, reduction in future risk and improvement in quality of life (QoL). Guideline-based pharmacologic therapies and the effect of inhaled steroids and bronchodilators have been widely studied over the past decades. We provide an overview of the available evidence on pulmonary rehabilitation as a nonpharmacologic therapy in asthmatic patients.Recent findingsRecently, some studies have highlighted the promising role of nonpharmacologic therapies in asthma, such as pulmonary rehabilitation demonstrating that a pulmonary rehabilitation programme consisting of exercise training, breathing retraining, educational and psychological support, improve exercise capacity, asthma control and QoL and reduce dyspnea, anxiety, depression and bronchial inflammation at any step of the disease.SummaryPulmonary rehabilitation shows positive results on exercise tolerance, respiratory symptoms and QoL in asthmatic patients at any steps of the diseases. However, additional information is required to better characterize rehabilitation programmes in order to improve clinical care in asthma
DI-DA. non solo una didascalia / not just a caption
No full textTroppo lunghe, troppo brevi, enigmatiche,non esaustive o eccessive, poco visibili, non comprensibili... a tutti noi è capitato di lamentarci delle didascalie.
Perché? Forse perché il museo non è riuscito a stare al passo? Conosce i bisogni del suo pubblico? In un mondo di didascalie, come può la didascalia museale lasciare il segno? Quando interviene e a chi parla? Come parla e in quale veste? E poi, esistono regole nel crearla? Un lungo susseguirsi di domande ci invita a indagare questo dispositivo comunicativo, solo apparentemente un dettaglio, tanto dibattuto quanto determinante, sia in fase di realizzazione sia durante l’esperienza di visita. A seguito di un’approfondita ricognizione dello stato dell’arte, grazie
all’espediente dell’intervista si intende aprire l’argomentazione a visioni,
approcci ed esperienze che offrano una pluralità di sguardi e voci
Prospects of rehabilitation in respiratory diseases
No full textLe malattie respiratorie sono fra le prime cause di mortalità e morbilità. In particolar modo la Broncopneumopatia Cronica Ostruttiva (BPCO), tra le malattie respiratorie, si impone oggi, e lo farà ancor di più nel futuro, alla nostra attenzione per la sua rilevanza clinico-epidemiologica e socio-assistenziale fino a costituire una delle aree prioritarie in pubblica sanità. La BPCO è una sindrome clinica eterogenea e complessa caratterizzata da limitazione al flusso espiratorio, nonostante presenti una storia naturale variabile, è una malattia irreversibile ed evolutiva.
Sono molteplici gli approcci terapeutici, farmacologici e non, nel trattamento di tale patologia, aventi come obiettivi principali quello di prevenire e controllare i sintomi, ridurre la frequenza e la gravità delle riacutizzazioni, con conseguente riduzione di ricoveri ospedalieri, migliorare la qualità di vita e la tolleranza allo sforzo. Un ruolo fondamentale è rivestito dalla terapia farmacologica che tuttavia si è rivelata incapace di arrestare e/o modificare la progressiva riduzione del quadro funzionale respiratorio, elemento caratteristico della malattia. Tra le modalità di trattamento non farmacologico emerge, raccomandata da forti evidenze scientifiche che ne documentano l’efficacia, specie in rapporto alla riduzione del numero di riacutizzazioni e quindi di ospedalizzazioni, la Riabilitazione Respiratoria (RR). Approcci globali di trattamento della patologia respiratoria comprendenti Programmi Riabilitativi, si sono sviluppati in questi ultimi anni assumendo un ruolo primario nella gestione dei pazienti, soprattutto se anziani, con problemi respiratori, tanto da avere una influenza preminente nella storia naturale delle malattie respiratorie. I Programmi di Riabilitazione Respiratoria (PRR) sono rivolti alla gestione di tutta la storia naturale della malattia,dalla insorgenza dei primi sintomi fino alla gestione della invalidità conseguente alla Insufficienza Respiratoria (IR) in fase terminale. Dunque, se fino a pochi anni fa i PRR potevano essere considerati una parte (forse secondaria) della pneumologia, oggi la RR è idealmente una strategia di trattamento globale indirizzata a tutte le componenti della malattia polmonare cronica e progressiva. Definita come “un insieme multidimensionale di servizi diretti a persone con malattie polmonari e alle loro famiglie, disolito da parte di un team interdisciplinare di specialisti con lo scopo di raggiungere e mantenere il massimo livello di indipendenza di attività nella comunità”, la RR pur non arrestando il progressivo peggioramento fisiopatologico si è dimostrata capace di incidere sulla storia naturale della malattia. Infatti, vi è evidenza scientifica che i PRR in pazienti con malattie croniche respiratorie hanno effetti clinici positivi, migliorano la dispnea e il controllo della malattia
- …
